Pandemic and seasonal H1N1 influenza hemagglutinin-specific T cell responses elicited by seasonal influenza vaccination

Vaccine. 2010 Dec 6;28(52):8258-67. doi: 10.1016/j.vaccine.2010.10.077. Epub 2010 Nov 2.

Abstract

Understanding whether seasonal influenza vaccines can elicit antibody and T cell responses against the 2009 pandemic H1N1 strain is important. We compared T cell and antibody responses elicited by trivalent inactivated influenza vaccine (TIV) and live attenuated influenza vaccine (LAIV) in healthy adults. Both vaccines boosted pre-existing T cells to the seasonal and pandemic hemagglutinin (HA) but responses were significantly greater following immunization with LAIV. Antibody titers were significantly boosted only by TIV. The relationship between antibody and T cell responses and the effect of the magnitude of pre-existing immunity on vaccine-induced responses were also evaluated. Cross reactive T cell responses to the pandemic H1N1 HA existed among the cohort before the circulation of the virus to varying degrees and these responses were boosted by seasonal vaccination.

MeSH terms

  • Adolescent
  • Adult
  • Antibodies, Viral / blood
  • Cross Reactions
  • Hemagglutinins, Viral / immunology*
  • Humans
  • Influenza A Virus, H1N1 Subtype / immunology*
  • Influenza Vaccines / immunology*
  • Middle Aged
  • T-Lymphocytes / immunology*
  • Vaccines, Attenuated / immunology
  • Vaccines, Inactivated / immunology
  • Young Adult

Substances

  • Antibodies, Viral
  • Hemagglutinins, Viral
  • Influenza Vaccines
  • Vaccines, Attenuated
  • Vaccines, Inactivated
  • hemagglutinin fusogenic peptide, influenza virus